News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
GlaxoSmithKline Two-in-one Prostate Drug Approved in Europe
March 31, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- Duodart, a two-in-one prostrate drug from GlaxoSmithKline (GSK.L), has been approved in Europe, the British drugmaker said on Wednesday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
GlaxoSmithKline
MORE ON THIS TOPIC
Earnings
Biopharma CEOs Can’t Dodge Policy Questions as Trump Lobs Wrench into Earnings Season
August 6, 2025
·
6 min read
·
Annalee Armstrong
Podcast
FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More
August 6, 2025
·
2 min read
·
Heather McKenzie
Regulatory
Report of Patient Deaths Sends Agios Shares Seesawing
August 5, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Scientists Behind Trial of Replimmune’s Tumor Destroyer Protest FDA’s Rejection
August 5, 2025
·
2 min read
·
Tristan Manalac
